Latest Insider Transactions at Generation Bio Co. (GBIO)
This section provides a real-time view of insider transactions for Generation Bio Co. (GBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Generation Bio Co. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Generation Bio Co.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.86%
|
-
|
|
Apr 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,879
-0.54%
|
$27,516
$4.5 P/Share
|
|
Apr 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,437
+1.82%
|
-
|
|
Apr 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-7.78%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+20.95%
|
-
|
|
Apr 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-7.78%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+20.95%
|
-
|
|
Apr 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-0.61%
|
$8,732
$4.5 P/Share
|
|
Apr 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,437
+2.03%
|
-
|
|
Jan 26
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,695
-100.0%
|
$13,475
$5.56 P/Share
|
|
Jan 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-11.11%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+24.28%
|
-
|
|
Jan 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-1.43%
|
$7,150
$5.1 P/Share
|
|
Jan 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.96%
|
-
|
|
Jan 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-1.16%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+3.25%
|
-
|
|
Jan 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,122
-0.65%
|
$40,610
$5.1 P/Share
|
|
Jan 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,438
+1.84%
|
-
|
|
Jan 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-11.11%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+24.28%
|
-
|
|
Jan 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-34.67%
|
$7,150
$5.1 P/Share
|
|
Jan 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+50.0%
|
-
|
|
Jan 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-0.73%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+2.06%
|
-
|
|
Jan 10
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,865
-100.0%
|
$7,460
$4.57 P/Share
|
|
Jan 09
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,865
-1.91%
|
$9,325
$5.11 P/Share
|
|
Jan 05
2023
|
Ronald Harold Wilfred Cooper |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+50.0%
|
$47,500
$5.12 P/Share
|
|
Oct 27
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,914
-100.0%
|
$14,570
$5.03 P/Share
|
|
Oct 15
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-29.36%
|
$6,055
$5.61 P/Share
|
|
Oct 15
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+50.0%
|
-
|
|
Oct 15
2022
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,184
-12.17%
|
$10,920
$5.61 P/Share
|
|
Oct 15
2022
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+29.3%
|
-
|
|
Oct 15
2022
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-1.25%
|
$6,055
$5.61 P/Share
|
|
Oct 15
2022
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+4.08%
|
-
|
|
Oct 15
2022
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,184
-1.01%
|
$10,920
$5.61 P/Share
|
|
Oct 15
2022
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+3.33%
|
-
|
|
Oct 15
2022
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,184
-0.63%
|
$10,920
$5.61 P/Share
|
|
Oct 15
2022
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+2.1%
|
-
|
|
Oct 15
2022
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,184
-12.17%
|
$10,920
$5.61 P/Share
|
|
Oct 15
2022
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+29.3%
|
-
|
|
Oct 15
2022
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,395
-0.84%
|
$51,975
$5.61 P/Share
|
|
Oct 15
2022
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,438
+1.87%
|
-
|
|
Sep 29
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,828
-100.0%
|
$14,140
$5.24 P/Share
|
|
Sep 19
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
15,750
+7.59%
|
$78,750
$5.26 P/Share
|
|
Sep 16
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
33,481
+15.98%
|
$167,405
$5.48 P/Share
|
|
Sep 15
2022
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,610
-61.98%
|
$23,050
$5.32 P/Share
|
|
Sep 15
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
17,147
+10.74%
|
$85,735
$5.41 P/Share
|
|
Sep 14
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
5,600
+4.27%
|
$28,000
$5.29 P/Share
|
|
Sep 13
2022
|
Charles A Rowland Jr |
BUY
Open market or private purchase
|
Direct |
18,784
+13.55%
|
$93,920
$5.2 P/Share
|
|
Jul 15
2022
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,150
-1.16%
|
$99,050
$7.18 P/Share
|